Why is Medicover AB ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Healthy long term growth as Net Sales has grown by an annual rate of 20.29%
3
With a growth in Net Profit of 108.14%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at SEK 3,144.04 MM
- ROCE(HY) Highest at 15.47%
- NET SALES(Q) Highest at SEK 6,697.44 MM
4
With ROE of 12.45%, it has a fair valuation with a 7.38 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -5.84%, its profits have risen by 155.1% ; the PEG ratio of the company is 0.4
5
Below par performance in long term as well as near term
- Along with generating -5.84% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Medicover AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Medicover AB for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Medicover AB
-5.84%
-0.19
29.65%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality key factors
Factor
Value
Sales Growth (5y)
20.29%
EBIT Growth (5y)
21.80%
EBIT to Interest (avg)
3.30
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
1.35
Sales to Capital Employed (avg)
1.65
Tax Ratio
28.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.18%
ROCE (avg)
11.54%
ROE (avg)
9.18%
Valuation Key Factors 
Factor
Value
P/E Ratio
59
Industry P/E
Price to Book Value
7.38
EV to EBIT
33.60
EV to EBITDA
12.22
EV to Capital Employed
3.25
EV to Sales
1.89
PEG Ratio
0.39
Dividend Yield
0.03%
ROCE (Latest)
9.68%
ROE (Latest)
12.45%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK 3,144.04 MM
ROCE(HY)
Highest at 15.47%
NET SALES(Q)
Highest at SEK 6,697.44 MM
RAW MATERIAL COST(Y)
Fallen by -3.33% (YoY
PRE-TAX PROFIT(Q)
At SEK 236.5 MM has Grown at 69.97%
NET PROFIT(Q)
At SEK 205.84 MM has Grown at 82.48%
-2What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)
Lowest at 0%
DIVIDEND PER SHARE(HY)
Lowest at SEK 7.64
Here's what is working for Medicover AB
Operating Cash Flow
Highest at SEK 3,144.04 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Net Sales
Highest at SEK 6,697.44 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (SEK MM)
Pre-Tax Profit
At SEK 236.5 MM has Grown at 69.97%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK 205.84 MM has Grown at 82.48%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Raw Material Cost
Fallen by -3.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Medicover AB
Dividend per share
Lowest at SEK 7.64
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (SEK)
Dividend Payout Ratio
Lowest at 0%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)






